MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$1,635,020
Unit: Dollar
Positive Cash Flow Breakdown
    • Accounts payable and accrued lia...
    • Stock based compensation
    • Prepaid expenses and deposits
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Additions to intellectual proper...
    • Operating lease liability
    • Others
Cash Flow
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Net loss
-1,992,981
-4,647,738
1,597,503
11,911,434
Stock based compensation
92,944
74,895
74,895
859,494
Depreciation and amortization
19,208
19,101
16,866
87,825
Impairment loss
0
0
-
247,364
Bad debt expense
-
-
-
0
Noncash lease expense
7,603
7,467
7,331
28,027
Unrealized loss on marketable securities
0
0
-22,093
-33,714
Lease accretion
1,664
1,802
1,937
9,047
Accounts receivable
6,969
-46,015
-280,314
213,881
Prepaid expenses and deposits
-85,081
-391,739
-256,919
-55,313
Long-term receivables
1
0
0
438
Accounts payable and accrued liabilities
167,768
-1,242,824
-37,613
396,637
Operating lease liability
-9,337
-9,335
-9,337
-37,093
Deferred revenue
0
0
0
-4,962
Net cash used in operating activities
-1,635,020
-2,163,872
-984,098
-10,450,387
Short-term investments
-837
2,001
-
143,267
Additions to intellectual property
26,252
15,094
5,099
75,106
Purchase of equipment
0
40,816
0
24,646
Net cash used in investing activities
-27,089
-53,909
-5,099
-243,019
Proceeds from exercise of stock options
-
-
-
0
Proceeds from shares sold for cash
0
3,044,054
3,474,051
6,046,163
Proceeds from exercise of warrants
-
-
-
0
Net cash from (used in) financing activities
0
3,044,054
3,474,051
6,046,163
Effect of exchange rate changes on cash
8,971
20,635
-5,744
-50,519
Net change in cash for the period
-1,653,138
846,908
2,479,110
-4,697,762
Cash at beginning of period
4,281,233
4,281,233
1,802,123
6,499,885
Cash at end of period
3,475,003
5,128,141
4,281,233
1,802,123
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Effect of exchange ratechanges on cash$8,971 Net change in cashfor the period-$1,653,138 Canceled cashflow$8,971 Accounts payable andaccrued liabilities$167,768 Stock basedcompensation$92,944 Prepaid expenses anddeposits-$85,081 Depreciation andamortization$19,208 Noncash lease expense$7,603 Lease accretion$1,664 Net cash used inoperating activities-$1,635,020 Net cash used ininvesting activities-$27,089 Canceled cashflow$374,268 Net loss-$1,992,981 Additions to intellectualproperty$26,252 Short-term investments-$837 Operating lease liability-$9,337 Accounts receivable$6,969 Long-term receivables$1

Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Corp. (LEXX)